Arbutus Biopharma (ABUS) Other Operating Expenses (2013 - 2026)

Arbutus Biopharma has disclosed Other Operating Expenses across 14 years of filings, most recently posting $209000.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $209000.0, down 30.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.2 million (down 615.85% YoY), and the FY2025 annual result was -$1.8 million, down 169.71% from the prior year.
• Other Operating Expenses came in at $209000.0 for Q1 2026 at Arbutus Biopharma, up from -$2.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.9 million in Q4 2024 to a low of -$12.0 million in Q2 2025.
• The 5-year median for Other Operating Expenses is $211000.0 (2024), against an average of -$525235.3.
• Across the five-year window, Other Operating Expenses jumped 733.68% in 2022 and sank 5775.36% in 2025, its largest moves.
• Arbutus Biopharma's Other Operating Expenses stood at $1.6 million in 2022, then plunged by 85.89% to $227000.0 in 2023, then soared by 732.6% to $1.9 million in 2024, then plunged by 240.58% to -$2.7 million in 2025, then jumped by 107.87% to $209000.0 in 2026.
• The last three Other Operating Expenses figures came in at $209000.0 (Q1 2026), -$2.7 million (Q4 2025), and $268000.0 (Q3 2025), per Business Quant data.